BlackRock »

Lyra Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $769k 3.0M 0.26

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Lyra Therapeutics

Perceptive Advisors
Citadel Advisors
BlackRock
BlackRock
Samsara BioCapital
Vanguard Group
Ikarian Capital
Sei Investments
Morgan Stanley
Geode Capital Management
Two Sigma Advisers
Two Sigma Investments
State Street Corporation
Everhart Financial Group
Northern Trust

View all funds holding Lyra Therapeutics